Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
62.76 EUR | -0.16% |
|
+2.21% | -8.79% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.79 for the current period. Therefore, the company is undervalued.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.79% | 861.27Cr | - | ||
-3.41% | 136.04Cr | D | ||
-11.94% | 129.82Cr | B+ | ||
-0.64% | 122.69Cr | - | ||
-30.35% | 73Cr | - | - | |
-.--% | 61Cr | - | - | |
+7.32% | 48Cr | - | ||
+2.83% | 44Cr | - | - | |
-35.03% | 29Cr | - | - | |
-66.61% | 26Cr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.